List of Leo Pharma patents

Patents where

Current Assignee

Name

Leo Pharma

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 8980905 Benzodioxole or benzodioxepine heterocyclic compounds as phosphodiesterase inhibitors	Patent 8980905 was granted and assigned to Leo Pharma on March, 2015 by the United States Patent and Trademark Office.		Leo Pharma	United States Patent and Trademark Office	8980905	March 17, 2015
‌ US Patent 8952162 Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases	Patent 8952162 was granted and assigned to Leo Pharma on February, 2015 by the United States Patent and Trademark Office.		Leo Pharma	United States Patent and Trademark Office	8952162	February 10, 2015
‌ US Patent 10906915 Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors	Patent 10906915 was granted and assigned to Leo Pharma on February, 2021 by the United States Patent and Trademark Office.	Leo Pharma	Leo Pharma	United States Patent and Trademark Office	10906915	February 2, 2021
‌ US Patent D678783 Applicator for applying preparations to the skin	Patent D678783 was granted and assigned to Leo Pharma on March, 2013 by the United States Patent and Trademark Office.		Leo Pharma	United States Patent and Trademark Office	D678783	March 26, 2013
‌ US Patent 8940761 [1,2,4]triazolopyridines and their use as phosphodiesterase inhibitors	Patent 8940761 was granted and assigned to Leo Pharma on January, 2015 by the United States Patent and Trademark Office.	Leo Pharma	Leo Pharma	United States Patent and Trademark Office	8940761	January 27, 2015
‌ US Patent 9181248 [1,2,4]triazolopyridines and their use as phosphodiesterase inhibitors	Patent 9181248 was granted and assigned to Leo Pharma on November, 2015 by the United States Patent and Trademark Office.	Leo Pharma	Leo Pharma	United States Patent and Trademark Office	9181248	November 10, 2015
‌ US Patent 9908894 Methods for the preparation of 1,3-benzodioxole heterocyclic compounds	Patent 9908894 was granted and assigned to Leo Pharma on March, 2018 by the United States Patent and Trademark Office.	Leo Pharma	Leo Pharma	United States Patent and Trademark Office	9908894	March 6, 2018
‌ US Patent 11065257 Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors	Patent 11065257 was granted and assigned to Leo Pharma on July, 2021 by the United States Patent and Trademark Office.	Leo Pharma	Leo Pharma	United States Patent and Trademark Office	11065257	July 20, 2021
‌ US Patent RE39706 Crystalline form of a vitamin D analogue	Patent RE39706 was granted and assigned to Leo Pharma on June, 2007 by the United States Patent and Trademark Office.		Leo Pharma	United States Patent and Trademark Office	RE39706	June 26, 2007
‌ US Patent D725470 Cartridge	Patent D725470 was granted and assigned to Leo Pharma on March, 2015 by the United States Patent and Trademark Office.	Leo Pharma	Leo Pharma	United States Patent and Trademark Office	D725470	March 31, 2015
‌ US Patent 9273064 Benzodioxole or benzodioxepine heterocyclic compounds as phosphodiesterase inhibitors	Patent 9273064 was granted and assigned to Leo Pharma on March, 2016 by the United States Patent and Trademark Office.	Leo Pharma	Leo Pharma	United States Patent and Trademark Office	9273064	March 1, 2016
‌ US Patent 9637499 Benzodioxole or benzodioxepine heterocyclic compounds as phosphodiesterase inhibitors	Patent 9637499 was granted and assigned to Leo Pharma on May, 2017 by the United States Patent and Trademark Office.	Leo Pharma	Leo Pharma	United States Patent and Trademark Office	9637499	May 2, 2017
‌ US Patent 10934282 Heteroaromatic modulators of the retinoid-related orphan receptor gamma	Patent 10934282 was granted and assigned to Leo Pharma on March, 2021 by the United States Patent and Trademark Office.	Leo Pharma	Leo Pharma	United States Patent and Trademark Office	10934282	March 2, 2021
‌ US Patent 9233964 Sulfamide piperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use therof	Patent 9233964 was granted and assigned to Leo Pharma on January, 2016 by the United States Patent and Trademark Office.		Leo Pharma	United States Patent and Trademark Office	9233964	January 12, 2016
‌ US Patent 8350026 VEGF-2 receptor and protein tyrosine kinase inhibitors and pharmaceutical use thereof	Patent 8350026 was granted and assigned to Leo Pharma on January, 2013 by the United States Patent and Trademark Office.		Leo Pharma	United States Patent and Trademark Office	8350026	January 8, 2013
‌ US Patent 10130640 Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid	Patent 10130640 was granted and assigned to Leo Pharma on November, 2018 by the United States Patent and Trademark Office.	Leo Pharma	Leo Pharma	United States Patent and Trademark Office	10130640	November 20, 2018
‌ US Patent 8338431 Phosphodiesterase inhibitors	Patent 8338431 was granted and assigned to Leo Pharma on December, 2012 by the United States Patent and Trademark Office.		Leo Pharma	United States Patent and Trademark Office	8338431	December 25, 2012
‌ US Patent 9487494 Cyclic hydrocarbon compounds for the treatment of diseases	Patent 9487494 was granted and assigned to Leo Pharma on November, 2016 by the United States Patent and Trademark Office.		Leo Pharma	United States Patent and Trademark Office	9487494	November 8, 2016
‌ US Patent 8946474 Polymorphic form of a calcimimetic compound	Patent 8946474 was granted and assigned to Leo Pharma on February, 2015 by the United States Patent and Trademark Office.		Leo Pharma	United States Patent and Trademark Office	8946474	February 3, 2015
‌ US Patent 11377425 Small molecule modulators of IL-17	Patent 11377425 was granted and assigned to Leo Pharma on July, 2022 by the United States Patent and Trademark Office.	Leo Pharma	Leo Pharma	United States Patent and Trademark Office	11377425	July 5, 2022
‌ US Patent 9056814 Polymorphic form of a calcimimetic compound	Patent 9056814 was granted and assigned to Leo Pharma on June, 2015 by the United States Patent and Trademark Office.		Leo Pharma	United States Patent and Trademark Office	9056814	June 16, 2015
‌ US Patent D718130 Applicator with cap	Patent D718130 was granted and assigned to Leo Pharma on November, 2014 by the United States Patent and Trademark Office.	Leo Pharma	Leo Pharma	United States Patent and Trademark Office	D718130	November 25, 2014
‌ US Patent 9238056 Cyclic peptide and conjugate thereof for binding to keratinocytes	Patent 9238056 was granted and assigned to Leo Pharma on January, 2016 by the United States Patent and Trademark Office.		Leo Pharma	United States Patent and Trademark Office	9238056	January 19, 2016
‌ US Patent 10494363 Non-steroidal glucocorticoid receptor modulators for local drug delivery	Patent 10494363 was granted and assigned to Leo Pharma on December, 2019 by the United States Patent and Trademark Office.	Leo Pharma	Leo Pharma	United States Patent and Trademark Office	10494363	December 3, 2019
‌ US Patent D727167 Applicator	Patent D727167 was granted and assigned to Leo Pharma on April, 2015 by the United States Patent and Trademark Office.	Leo Pharma	Leo Pharma	United States Patent and Trademark Office	D727167	April 21, 2015

Results per page:

59 results

0 selected

59 results

0 selected